Clinical trials
T Cells clinical trials
Below are recruiting t cells clinical trials, each written for real people, not researchers. We’re tracking 5,684 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04156893RecruitingPhase 1/Phase 2
RH-matched blood transfusions for sickle cell patients
This study tests whether giving red blood cells matched to your child’s RH (a blood marker) can improve safety and fit for people with sickle cell disease who need regular transfusions. It may help reduce mismatches by using blood units selected to match the child’s blood type more closely.
Philadelphia, PennsylvaniaAges 6 months+ - NCT04402788RecruitingPhase 2/Phase 3
Radiation added to immune therapy for extensive small cell lung cancer
This trial tests whether adding radiation therapy to standard immune therapy (atezolizumab) after initial chemo can help people with extensive-stage small cell lung cancer live longer and control the cancer better. You must have a good response (partial response) or stable disease after initial treatment, plus several lab/imaging checks to confirm safety.
Birmingham, AlabamaAges 18 years+ - NCT03851445RecruitingPhase 2/Phase 3
Lung cancer screening trial using tumor and blood test results
This trial helps sort people with previously treated lung cancer into the best next treatment options by using new tumor tissue (and sometimes blood) test results. It may help you get matched to therapies based on features like PD-L1 and other biomarkers.
Birmingham, AlabamaAges 18 years+ - NCT00902447Recruiting
Blood and tissue collection for future research studies
This trial is a tissue and blood bank that collects samples for future research. You may be asked to give blood and/or tissue again later, but it is meant to be done without interfering with your care.
Manhasset, New YorkAges 18–100 - NCT05605574Recruiting
Advance care planning talks for young transplant patients
This study tests a structured set of conversations about future medical care (advance care planning) for adolescents and young adults who are preparing for a stem cell transplant. It also involves a caregiver (and the care team) to help ensure the discussions are understood, documented, and completed at the right times.
Baltimore, MarylandAges 18–120 - NCT03571568RecruitingPhase 1/Phase 2
Study of BI-1206 plus rituximab, with or without acalabrutinib
This early-phase study tests BI-1206 combined with rituximab, and possibly adds acalabrutinib, in people with certain slow-growing B-cell lymphomas that have come back or did not respond to prior treatment. The goal is to see whether this treatment approach shrinks lymphoma safely and effectively.
Atlanta, GeorgiaAges 18 years+ - NCT03000244Recruiting
Long-term follow-up after stem cell or gene therapy
This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.
Bethesda, MarylandAges 4–120 - NCT03546829RecruitingPhase 1
Testing targeted radiation plus short anti-microbial treatment
This early safety study tests a combination of focused radiation and a targeted anti-microbial (antibiotic/antifungal/antiviral/anti-parasite) plan for certain lung cancer that is starting to progress in a few spots. It aims to see whether this approach is safe and helps control the small areas of progressing cancer after prior treatment.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07113795Enrolling by invitationEarly Phase 1
Chinese medicine and stem cells for Crohn's fistula
This trial tests a new approach that combines traditional Chinese medicine with stem cells to treat complex anal fistulas caused by Crohn's disease. It may help people whose Crohn's is not very active and who have not had major fistula surgery before.
Nanjing, JiangsuAges 18–60 - NCT02881970RecruitingPhase 1/Phase 2
Cord blood stem cell treatment for newborn brain injury
This early-phase study tests whether using a baby’s own cord blood stem cells is safe and feasible for newborns with brain injury from lack of oxygen around birth. It may help researchers find new ways to treat hypoxic-ischemic encephalopathy (brain injury due to oxygen deprivation) in addition to standard care like cooling.
MarseilleAges 1 day–3 days - NCT05124951RecruitingPhase 2
Tested a treatment for specific brain germ cell tumors
This Phase 2 trial studies WVI for children and young adults with a newly diagnosed germ cell tumor in one side of the basal ganglia/thalamus. It aims to see how well the treatment works for tumors without spread within the brain.
BeijingAges 3–30 - NCT02312830Enrolling by invitation
Study of long-term transplant survivors at one Belgian hospital
This study invites adults who had a donor (allogeneic) transplant at KU Leuven long ago to share health information during a scheduled checkup. It may help researchers better understand long-term outcomes and support needs after transplant.
Ages 18–100 - NCT05695222Recruiting
Skin cancer staging study for adults with squamous cell cancer
This study looks at how doctors stage (classify the extent of) a type of skin cancer called cutaneous squamous cell carcinoma. You may be helping researchers by allowing your clinical data to be used for research.
LondonAges 18–120 - NCT07165769RecruitingPhase 2
ZGR combo for newly diagnosed spleen lymphoma with large cells
This trial tests a combination of three drugs (zanubrutinib, obinutuzumab, and lenalidomide) for people newly diagnosed with splenic B-cell lymphoma that has large cells (prominent nucleoli). The goal is to see if this drug combination is safe and effective.
Tianjin, Tianjin MunicipalityAges 18–80 - NCT03541525Recruiting
Study on red blood cell-related diseases in families
This study looks at how red blood cells work in people who have a related condition—or who have family members with one. It may help researchers understand causes of these diseases and improve future care.
CotonouAges Any age - NCT06798623RecruitingPhase 1
ACL repair with stem cells from your own knee fat
This trial tests whether adding stem cells from your knee fat pad to a standard ACL reconstruction helps you heal better. It is for Houston Methodist patients who can do physical therapy there and meet basic health requirements.
Houston, TexasAges 18 years+ - NCT02161783Recruiting
Second transplant for blood stem cell graft failure
This trial studies treatment after a first stem cell transplant fails to produce lasting blood recovery. It may help people who need a second transplant because their counts never fully recovered or then dropped again.
Minneapolis, MinnesotaAges Any age - NCT06169956Recruiting
Study of nivolumab with chemo before lung cancer surgery
This study looks at how well the immunotherapy drug nivolumab (Opdivo) works when given with standard chemotherapy before surgery for people with a certain type of lung cancer that has not spread. It may help shrink the tumor before surgery.
Kempten (Allgäu), BavariaAges 18 years+ - NCT06489197RecruitingPhase 2
AK112 plus chemo for advanced esophageal cancer
This trial tests a new immunotherapy drug (AK112) combined with chemotherapy as a first treatment for advanced esophageal cancer that has spread or cannot be removed. It aims to see if this combination helps shrink tumors and controls the disease longer than chemotherapy alone.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT07450391RecruitingPhase 1/Phase 2
EBV-targeted cell therapy for EBV-related lymph disorders
This trial tests an experimental cell therapy that targets cells infected with the Epstein-Barr virus (EBV). It is for patients with certain blood cancers or post-transplant lymph disorders caused by EBV that have not responded to standard treatments or who cannot receive them.
Beijing, Beijing MunicipalityAges 18–70 - NCT06461351Recruiting
Long-term study of patients treated with Inaticabtagene Autoleucel
This study is a long-term follow-up for people who have already received Inaticabtagene Autoleucel, a type of cell therapy. It checks how patients are doing over time, and does not involve any new treatments.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07424157Recruiting
Long-term gene therapy follow-up study
This study follows patients who received gene therapy at Seattle Children's Hospital to check on their health and safety over time. It helps doctors understand how well the treatment works in the long run.
Seattle, WashingtonAges Any age - NCT06405516Recruiting
Platelet function after heart surgery
This study watches how well platelets (cells that help blood clot) work in people who have high-risk heart surgery using a heart-lung machine for more than 2 hours. The goal is to learn more about bleeding risks after surgery.
BernAges 18 years+ - NCT01728545Recruiting
Storing umbilical cord blood for future transplantation
This study collects and stores umbilical cord blood at birth so it can be used later for transplant. It also involves blood and cord blood testing to check for infections and key matching features.
Houston, TexasAges 18 years+
Hear when a new T Cells trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for t cells?
- Yes. Clin2 currently lists 5,684 recruiting t cells studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a t cells trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a t cells trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.